Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | CDC25A |
| Gene Name: | CDC25A |
| Protein Full Name: | M-phase inducer phosphatase 1 |
| Alias: | CDC25M3; EC 3.1.3.48; M-phase inducer phosphatase 1; MPIP1 |
| Mass (Da): | 59087 |
| Number AA: | 524 |
| UniProt ID: | P30304 |
| Locus ID: | 993 |
| COSMIC ID: | CDC25A |
| Gene location on chromosome: | 3p21 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 20426 |
| Percent of cancer specimens with mutations: | 0.37 |
| Normal role description: | CDC25A is a protein-dual specificity phosphatase. Involved in early embryonic development. It activates M-phase CDKs and is of importance for G1- to S-phase transition. Inhibits apoptosis signal-regulating kinase 1 (ASK1). A great variety of cancers show CDC25A overexpression. |